Literature DB >> 25918127

Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.

Elsayed Z Soliman1, Faye Lopez2, Wesley T O'Neal2, Lin Y Chen2, Lindsay Bengtson2, Zhu-Ming Zhang2, Laura Loehr2, Mary Cushman2, Alvaro Alonso2.   

Abstract

BACKGROUND: It has recently been reported that atrial fibrillation (AF) is associated with an increased risk of myocardial infarction (MI). However, the mechanism underlying this association is currently unknown. Further study of the relationship of AF with the type of MI (ST-segment-elevation MI [STEMI] versus non-ST-segment-elevation MI [NSTEMI]) might shed light on the potential mechanisms. METHODS AND
RESULTS: We examined the association between AF and incident MI in 14 462 participants (mean age, 54 years; 56% women; 26% blacks) from the Atherosclerosis Risk in Communities (ARIC) study who were free of coronary heart disease at baseline (1987-1989) with follow-up through December 31, 2010. AF cases were identified from study visit ECGs and by review of hospital discharge records. Incident MI and its types were ascertained by an independent adjudication committee. Over a median follow-up of 21.6 years, 1374 MI events occurred (829 NSTEMIs, 249 STEMIs, 296 unclassifiable MIs). In a multivariable-adjusted model, AF (n=1545) as a time-varying variable was associated with a 63% increased risk of MI (hazard ratio,1.63; 95% confidence interval, 1.32-2.02). However, AF was associated with NSTEMI (hazard ratio, 1.80; 95% confidence interval, 1.39-2.31) but not STEMI (hazard ratio, 0.49; 95% confidence interval, 0.18-1.34; P for hazard ratio comparison=0.004). Combining the unclassifiable MI group with either STEMI or NSTEMI did not change this conclusion. The association between AF and MI, total and NSTEMI, was stronger in women than in men (P for interaction <0.01 for both).
CONCLUSIONS: AF is associated with an increased risk of incident MI, especially in women. However, this association is limited to NSTEMI.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  atrial fibrillation; electrocardiography; epidemiology; myocardial infarction

Mesh:

Year:  2015        PMID: 25918127      PMCID: PMC4447576          DOI: 10.1161/CIRCULATIONAHA.114.014145

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  39 in total

1.  Atrial fibrillation begets myocardial infarction.

Authors:  Jonathan W Dukes; Gregory M Marcus
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

2.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

3.  Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm.

Authors:  Emmanuel I Skalidis; Evangelos A Zacharis; Dimitrios K Tsetis; Kostas Pagonidis; Gregory Chlouverakis; Spyridon Yarmenitis; Michalis Hamilos; Emmanuel G Manios; Panos E Vardas
Journal:  Am J Cardiol       Date:  2007-03-13       Impact factor: 2.778

4.  Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Elsayed Z Soliman; Ronald J Prineas; L Douglas Case; Zhu-ming Zhang; David C Goff
Journal:  Stroke       Date:  2009-02-12       Impact factor: 7.914

5.  Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study).

Authors:  Laura R Loehr; Wayne D Rosamond; Patricia P Chang; Aaron R Folsom; Lloyd E Chambless
Journal:  Am J Cardiol       Date:  2008-02-14       Impact factor: 2.778

6.  Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Lloyd E Chambless; Aaron R Folsom; A Richey Sharrett; Paul Sorlie; David Couper; Moyses Szklo; F Javier Nieto
Journal:  J Clin Epidemiol       Date:  2003-09       Impact factor: 6.437

Review 7.  Status of the epidemiology of atrial fibrillation.

Authors:  William B Kannel; Emelia J Benjamin
Journal:  Med Clin North Am       Date:  2008-01       Impact factor: 5.456

Review 8.  Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.

Authors:  Timothy Watson; Eduard Shantsila; Gregory Y H Lip
Journal:  Lancet       Date:  2009-01-10       Impact factor: 79.321

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

View more
  48 in total

Review 1.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study.

Authors:  Wesley T O'Neal; Waqas Qureshi; Suzanne E Judd; Stephen P Glasser; Lama Ghazi; LeaVonne Pulley; Virginia J Howard; George Howard; Elsayed Z Soliman
Journal:  Ann Behav Med       Date:  2015-12

3.  Arrhythmias: Atrial fibrillation increases risk of NSTEMI.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2015-05-19       Impact factor: 32.419

Review 4.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

Review 5.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

Review 6.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marín; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Europace       Date:  2017-02-01       Impact factor: 5.214

7.  Evaluation of Risk Prediction Models of Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Authors:  Joshua D Bundy; Susan R Heckbert; Lin Y Chen; Donald M Lloyd-Jones; Philip Greenland
Journal:  Am J Cardiol       Date:  2019-10-10       Impact factor: 2.778

8.  Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score.

Authors:  Daniele Pastori; Alessio Farcomeni; Daniela Poli; Emilia Antonucci; Francesco Angelico; Maria Del Ben; Roberto Cangemi; Gaetano Tanzilli; Gregory Yoke Hong Lip; Pasquale Pignatelli; Francesco Violi
Journal:  Intern Emerg Med       Date:  2015-10-15       Impact factor: 3.397

Review 9.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

10.  Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ning Ding; Lucia Kwak; Shoshana H Ballew; Bernard Jaar; Ron C Hoogeveen; Christie M Ballantyne; A Richey Sharrett; Aaron R Folsom; Gerardo Heiss; Maya Salameh; Josef Coresh; Alan T Hirsch; Elizabeth Selvin; Kunihiro Matsushita
Journal:  Atherosclerosis       Date:  2018-04-30       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.